Lung cancer is one of the most common and serious types of cancer. Detected early and treated quickly, the chances of achieving successful lung cancer treatment outcomes are promising. Even among those diagnosed with stage 4 lung cancer, many are living longer and experiencing extended periods during which their cancer and its symptoms are well managed.
While the most common cause of lung cancer is smoking, it’s important to recognise that lung cancers occur in people who have never smoked, too. If you have smoked, there is no judgement. Risk factors and known causes of lung cancer also include a family history of lung cancer, exposure to secondhand smoke, exposure to radon gas, asbestos exposure, enviromental pollution and a history of respiratory conditions.
There are two main types of lung cancer: non-small cell lung cancer (NSCLC), which is the most common type of cancer, accounting for about 80 to 85 out of 100 cases here in the UK. On the other hand, small-cell lung cancer (SCLC) is less common but at high risk of spreading more quickly. The cancer stage describes how much and where it is in the body; as a rule, the lower the number, the less the cancer has spread.
Multiple factors impact the treatment outcomes of lung cancer, such as the cancer stage at diagnosis, an individual’s overall health, and the genetic characteristics of the cancer cells. Additionally, factors like smoking history, age, gender and your own lung cancer treatment preferences also play a role. Early detection of lung cancer significantly improves treatment outcomes. Lung cancer treatments like surgery, radiotherapy, immunotherapy, targeted therapies, and clinical trials—or different combinations of these approaches—are more successful when used in the early stages.
I am now able to offer more people with lung cancer treatments with the potential for a cure than ever before. As one of a few UK cancer doctors with access to all the latest targeted lung cancer treatments, I can provide curative lung cancer options to individuals who might only be offered palliative treatment elsewhere.
If you have only been offered palliative lung cancer treatment elsewhere and your doctor hasn’t discussed proton beam therapy, MR-linac treatment, clinical trials, stereotactic ablative radiotherapy (SABR) or a combination treatment approach with you, then we should definitely talk about your lung cancer treatment options.
My private practice is affiliated with a distinguished group of hospitals in London, tailored to meet your individual needs through compassionate cancer care. One significant advantage of private hospitals is their flexibility; I can find the most effective cancer treatment and treatment centre for you, and you can decide when to undergo treatment. I am here to ensure that your lung cancer treatment causes the least disruption to your well-being and to support you in managing any side effects quickly and effectively, all while prioritising your well-being.
If you are not based in London, I welcome patients from across the UK and provide initial video consultations to collaboratively develop affordable, personalised cancer care and treatment plans. Additionally, should you require accommodation, I can assist in arranging a comfortable and convenient place for you to stay near my London practices.
